NCT00024648View on ClinicalTrials.gov

Study to Determine Maximum Tolerated Dose of LErafAON Combined With Radiotherapy in Patients With Advanced Malignancies

PHASE1CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

March 31, 2001

Study Completion Date

December 31, 2004

Conditions
Neoplasms
Interventions
DRUG

LErafAON

Trial Locations (4)

19111

Fox Chase Cancer Center, Philadelphia

19140

Temple University Cancer Center, Philadelphia

20007

Georgetown University, Washington D.C.

60637

University of Chicago Medical Center, Chicago

Sponsors
All Listed Sponsors
collaborator

Georgetown University

OTHER

lead

INSYS Therapeutics Inc

INDUSTRY

NCT00024648 - Study to Determine Maximum Tolerated Dose of LErafAON Combined With Radiotherapy in Patients With Advanced Malignancies | Biotech Hunter | Biotech Hunter